STAT+: Pharmalittle: We’re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more

<iframe
  src="https://statesidedaily.com/embed/cluster/38cb7d5070b565932100eef6ae96c862c0453f60"
  width="100%" height="320"
  style="border:0;max-width:680px"
  loading="lazy"
  title="STAT+: Pharmalittle: We&#8217;re reading about Novo licensing a Chinese obesity pill, Merck pulling an antibiotic, and more"></iframe>